Navigation Links
EntreMed Receives Deloitte Technology Fast 50 Award
Date:10/3/2007

; the early-stage products under development; results in preclinical models are not necessarily indicative of clinical results, uncertainties relating to preclinical and clinical trials; success in the clinical development of any products; dependence on third parties; future capital needs; and risks relating to the commercialization, if any, of the Company's proposed products (such as marketing, safety, regulatory, patent, product liability, supply, competition and other risks).

About Deloitte

Deloitte refers to one or more of Deloitte Touche Tohmatsu, a Swiss Verein, its member firms, and their respective subsidiaries and affiliates. As a Swiss Verein (association), neither Deloitte Touche Tohmatsu nor any of its member firms has any liability for each other's acts or omissions. Each of the member firms is a separate and independent legal entity operating under the names "Deloitte," "Deloitte & Touche," "Deloitte Touche Tohmatsu," or other related names. Services are provided by the member firms or their subsidiaries or affiliates and not by the Deloitte Touche Tohmatsu Verein. Deloitte & Touche USA LLP is the U.S. member firm of Deloitte Touche Tohmatsu. In the United States, services are provided by the subsidiaries of Deloitte & Touche USA LLP (Deloitte & Touche LLP, Deloitte Consulting LLP, Deloitte Financial Advisory Services LLP, Deloitte Tax LLP, and their subsidiaries), and not by Deloitte & Touche USA LLP. 2007 Deloitte Development LLC. All rights reserved.

CONTACT:

Ginny Dunn

Associate Director, Corporate Communications & Investor Relations

EntreMed, Inc.

240.864.2643


'/>"/>
SOURCE EntreMed, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Infant receives first bloodless liver transplant
2. British MPs Say Prostate Cancer Receives Low Priority in the NHS
3. Fifth US Patient Receives Artificial Heart
4. Northfield Labs Receives FDA Comments
5. Abbott Receives CE Mark Certification
6. Zactima Receives Fast Track Designation By The FDA
7. East London Receives World Class New Private Hospital Facility
8. Brinda Karat Receives Legal Notice over Ramdev Issue
9. Quake-Hit Pakistan Receives 30 Field Hospitals From Cuba
10. Medtronic’s Insulin Pump Receives Regulatory Approva
11. Aurobindo Receives Approval from USFDA for anti-AIDS drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)NEW YORK, Dec. 4 Thousands of KPMG LLP employees came together in more than 90 offices nationwide today, to participate in a community service event which combines the audit, tax and advisory firm,s
(Date:12/4/2009)KANSAS CITY, Mo., Dec. 4 The large, two-day free health clinic sponsored by the National Association of Free Clinics (NAFC) in Kansas City on Wednesday and Thursday is not just for the sick but also
(Date:12/4/2009)Late recurrence is a risk for some pediatric cancers, particularly Ewing sarcomas and tumors of the central nervous system, according to a new study published online December 4 in the Journal of the
(Date:12/4/2009)Rockville, MD "Why is it that men can be bastards and women must wear pearls and smile?" wrote author Lynn Hecht Schafran. The answer, according to an article in the Journal of Vision , may lie in
(Date:12/4/2009)BOSTON, Dec. 4 Substantial progress has been made over the last 15 years in the healthcare community,s ability to diagnose and treat epilepsy and its complications. Yet this progress in epilepsy man
Breaking Medicine News(10 mins):Health News:KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children 2Health News:Free Health Clinic Event Is Not Just for the Sick 2Health News:Are angry women more like men? 2Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 2Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 3Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 4
...amia will have an ultra-modern hospital in the cam...The university and the Royal Embassy of Saudi Arab...Abdullah Bin Abdul Aziz Health Center with an inve...uthorities at the university here. Spread o...
...ded a commitment for more funding if talks were to... of the NHS Wheelchair// and Seating Service indic.... But the Scottish Executive has agreed a one-off ...tly. Meanwhile BBC Scotland has come to understand...
...ears back Timothy Bingham was struck down by a mys...ter him- the Bingham syndrome. The boy then ag...cks, which rendered him totally paralyzed. It left...Great Ormond Street children’s hospital have disco...
...ge blood vessels in women with preeclampsia (PE)./...life-threatening increases in high blood pressure ...gnized that substances called "microparticles" rel...teins were found in microparticles. The team,...
...olumbia have discovered new non-toxic and targeted...r. // The research conducted by UBC stem cell a...odocalyxin – which the researchers had previously ...stasize. Metastatic cancer is invasive cancer that...
...s has shown the dangerous increase in Type 1 diabe...s//. The number of children below five years of ag...en five fold between 1985 and 2004. Type 1 d...Charity Diabetes UK, nearly 20,000 school going ch...
Other Medicine News:Health News:New Non-toxic Therapies for Breast, Ovarian Cancers 2
(Date:12/4/2009)SALT LAKE CITY, Dec. 4 Dynatronics Corporation (Nasdaq: DYNT ) announced it has signed a sole-source vendor agreement to provide therapy equipment and rehab supplies to Benchmark Physical Therapy wi
(Date:12/4/2009)LAKE FOREST, Ill., Dec. 4 Hospira, Inc. (NYSE: HSP ), a leading global specialty pharmaceutical and medication delivery company, today announced the launch of its next-generation 50 mL and 100 mL V
(Date:12/4/2009)BILLERICA, Mass., Dec. 4 Axsun Technologies, Inc., a wholly-owned subsidiary of Volcano Corporation (Nasdaq: VOLC ), today announced the initial development and successful testing of a novel integra
Breaking Medicine Technology:Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 3Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 3Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 5Akaza Research to Present and Exhibit at Upcoming DIA Annual Meeting 12481 1Akaza Research to Present and Exhibit at Upcoming DIA Annual Meeting 12481 2Low T Specialist reNEW MAN Promotes National Network of Doctors 48028 1Low T Specialist reNEW MAN Promotes National Network of Doctors 48028 2Low T Specialist reNEW MAN Promotes National Network of Doctors 48028 3Low T Specialist reNEW MAN Promotes National Network of Doctors 48028 4Bruce Plaxen Named 2008 Maryland Trial Lawyer of the Year by Maryland Association for Justice 48025 1Bruce Plaxen Named 2008 Maryland Trial Lawyer of the Year by Maryland Association for Justice 48025 2
...difficult preventable medical conditions to addr...wareness, education and training t...e providers,brace for an October deadline when Med...reventable medical conditions, more than 400 healt...o implement a zero-tolerance,approach to hospital-...
... yet Again Provided Structural Proof of, a Drug Ta... Characterizes, the Target of Anti-Epileptic Drug... Have Been Identified, STOCKHOLM, Se...d the first direct structural evidence of the mole... (SV2A) in mouse brain tissue. SV2A is,the unique ...
Other Medicine Technology:Nation's Foremost Health Care Leaders Kick Off Summit Focused on Zero-Tolerance Approach to Hospital-Acquired Infections 2Nation's Foremost Health Care Leaders Kick Off Summit Focused on Zero-Tolerance Approach to Hospital-Acquired Infections 3The First Direct Structural Evidence of SV2A has Been Revealed Thanks to Protein Tomography(TM), and Published in BBRC 2
Finntip Filter Tips, 10ul
...e safety precautions must be taken to anticipate t...ioactive, highly toxic, or infectious sample mater...ng the contamination risk caused by foreign DNA (e...lter have an integrated filter made of pure hydrop...
Avant E-Z Rack Premium Low Binding Pipet Tips
RNase-free Tips, 1000 l size
Medicine Products: